Canigen Parvo-C
Active substance
ATC code
Species
Dogs.
Indications
For active immunisation of dogs to prevent mortality, clinical signs and viral excretion following canine parvovirus infection.
Onset of immunity: 1 week.
Duration of immunity: 3 years.
Dose to be administered and administration route
Reconstitute the vaccine with 1 ml solvent or 1 ml (1 dose) of the inactivated vaccines listed in section 4.8.
Subcutaneous use.
Avoid contamination of vaccine with traces of chemical sterilising agents. Do not use chemicals such as disinfectant or spirit to disinfect the skin prior to inoculation.
Maternal antibodies can negatively interfere with the efficacy of a vaccine. Strict adherence to the vaccination programme is therefore recommended.
Vaccination programme:
Primary vaccination course:
A single injection should establish active immunity to disease caused by canine parvovirus infection in dogs of 10 weeks of age or older. Where earlier protection is required a first dose may be given to puppies from 4 weeks of age, but because maternally derived passive antibody can interfere with the response to vaccination a final dose at 10 weeks of age or older is generally recommended.
Booster vaccination:
It is recommended that dogs be revaccinated against canine parvovirus every 3 years.
Adverse reactions
A diffuse swelling, up to 5 mm in diameter, may commonly be observed at the site of injection. Occasionally this swelling may be hard and painful and last for up to 3 days post injection.
A transient acute hypersensitivity reaction – with signs that may include lethargy, facial oedema, pruritus, vomiting or diarrhoea – may occur shortly after vaccination in very rare cases. Such reaction may evolve to a more severe condition (anaphylaxis), which may be life-threatening with additional signs like dyspnoea and collapse. If such reactions occur, appropriate treatment is recommended.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
